Abstract
Prostate cancer is a common and aggressive cancer among men. Despite advances in treatment, the mechanisms involved in progression are still unclear. New prognostic markers are needed to better design patient-specific therapeutic regimens. The present study included 120 patients: 76 with prostate carcinoma, 12 with low-grade prostate intraepithelial lesions, 12 with high-grade prostate intraepithelial lesions, and 20 with benign prostatic hyperplasia. Immunohistochemical study was performed for Golgi phosphoprotein-3 (GOLPH3) and Y-box-binding protein-1 (YB-1) analysis. The correlation with clinicopathologic data and overall survival was analyzed. Both GOLPH3 and YB-1 showed increased expression from benign to malignant tumors. In prostate carcinoma, cytoplasmic GOLPH3 was associated with Gleason score, tumor stage, and androgen receptor status (P = .034, P < .001, and P = .008, respectively). Nuclear YB-1 expression was associated with Gleason score and androgen receptor status (P = .018 and P = .024, respectively). Cytoplasmic YB-1 expression was associated with Gleason score, tumor stage, and androgen receptor status (P = .008, P = .027, and P < .001, respectively). A high Gleason score (P = .004), high tumor stage (P < .001...Continue Reading
References
Apr 24, 2003·Cancer Science·Michihiko KuwanoKimitoshi Kohno
Jun 20, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Kimitoshi KohnoMichihiko Kuwano
Mar 26, 2004·The Prostate·Pepita Giménez-BonaféColleen C Nelson
Feb 14, 2006·The Journal of Urology·Jonathan I Epstein, Mehsati Herawi
Mar 31, 2006·Journal of Virology·Gabriel GlockzinPer Sonne Holm
Sep 11, 2008·BJU International·Ayman S MoussaJ Stephen Jones
Oct 18, 2008·Breast Cancer Research : BCR·Golareh HabibiSandra E Dunn
Jan 20, 2009·Oncogene·M R FinkbeinerS E Dunn
Mar 26, 2009·Cancer Research·Masaki ShiotaKimitoshi Kohno
May 5, 2009·Cancer Cell·Valentina EvdokimovaPoul H B Sorensen
Oct 17, 2009·BMC Genomics·Tammy L RomanuikMarianne D Sadar
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oleg GluzNadia Harbeck
Nov 26, 2009·BMC Cancer·Edgar DahlPeter R Mertens
Mar 25, 2010·Cancer Research·Karen ToSandra E Dunn
Apr 1, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenneth L Scott, Lynda Chin
Sep 17, 2010·PloS One·Jennifer H LawSandra E Dunn
Jun 10, 2011·Endocrine-related Cancer·Masaki ShiotaSeiji Naito
Aug 9, 2011·Oncology Reports·Osamu KunigouTakao Setoguchi
Aug 27, 2011·BMC Cancer·Steffen WedelRoman A Blaheta
Jun 7, 2012·Korean journal of urology·Joseph C KlinkEric A Klein
Aug 22, 2012·Journal of Translational Medicine·Huan LiMing Song
Sep 26, 2012·Diagnostic Pathology·Xing HuaHong Shen
Nov 8, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ben-Shun HuJian-Ping Li
Mar 19, 2013·Biochemical and Biophysical Research Communications·Xiuping ZhouRutong Yu
Mar 21, 2013·Current Opinion in Oncology·Gary R MacVicar, Maha H Hussain
Apr 25, 2013·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Tian Tian GuoBoon Huat Bay
Jul 11, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenjiro ImadaYoshinao Oda
Jul 16, 2013·Oncogene·N PanupinthuG B Mills
Mar 7, 2014·British Journal of Cancer·Y XueR Huang
Apr 8, 2014·Cancer Research·Emi TokudaTadaomi Takenawa
May 3, 2014·PLoS Genetics·Stefano SechiMaria Grazia Giansanti
Aug 27, 2014·Molecular Carcinogenesis·Xu ZhangRutong Yu
Oct 21, 2014·Journal of Cancer Epidemiology·Amal S IbrahimHossam Kamel
Nov 12, 2014·The Journal of Pathology·Ting DaiLibing Song
Mar 21, 2015·BioMed Research International·Filip PoelaertNicolaas Lumen
Apr 16, 2015·Journal of Cancer·Wenzhi LiXiang Wang